CME Group Inc. (NASDAQ:CME) Position Raised by Brown Brothers Harriman & Co.

Brown Brothers Harriman & Co. grew its position in shares of CME Group Inc. (NASDAQ:CME) by 17.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,546 shares of the financial services provider’s stock after acquiring an additional 1,736 shares during the quarter. Brown Brothers Harriman & Co.’s holdings in CME Group were worth $2,270,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Rathbones Group PLC increased its position in CME Group by 3.7% in the 2nd quarter. Rathbones Group PLC now owns 1,311,474 shares of the financial services provider’s stock valued at $257,836,000 after acquiring an additional 46,276 shares during the period. Plato Investment Management Ltd grew its stake in shares of CME Group by 2.9% in the second quarter. Plato Investment Management Ltd now owns 15,011 shares of the financial services provider’s stock worth $2,951,000 after purchasing an additional 422 shares in the last quarter. Element Capital Management LLC increased its holdings in shares of CME Group by 2.6% during the second quarter. Element Capital Management LLC now owns 30,790 shares of the financial services provider’s stock valued at $6,053,000 after purchasing an additional 790 shares during the period. Prosperity Consulting Group LLC raised its stake in shares of CME Group by 27.2% during the second quarter. Prosperity Consulting Group LLC now owns 1,401 shares of the financial services provider’s stock valued at $275,000 after purchasing an additional 300 shares in the last quarter. Finally, OV Management LLC lifted its holdings in CME Group by 1.4% in the second quarter. OV Management LLC now owns 8,115 shares of the financial services provider’s stock worth $1,595,000 after purchasing an additional 115 shares during the period. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ CME opened at $218.53 on Tuesday. The stock’s fifty day simple moving average is $206.16 and its 200 day simple moving average is $207.48. The stock has a market capitalization of $78.69 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 8.85 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $223.80.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. CME Group’s revenue was up 12.7% on a year-over-year basis. During the same quarter last year, the business posted $2.30 EPS. As a group, sell-side analysts forecast that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be issued a dividend of $1.15 per share. The ex-dividend date is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.10%. CME Group’s dividend payout ratio is currently 52.33%.

Insider Activity at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.30% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities analysts have commented on CME shares. JPMorgan Chase & Co. raised their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Piper Sandler reissued an “overweight” rating and set a $225.00 target price on shares of CME Group in a report on Tuesday, August 20th. Deutsche Bank Aktiengesellschaft increased their price target on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and lowered their price target for the company from $212.00 to $177.00 in a research report on Tuesday, September 3rd. Finally, Keefe, Bruyette & Woods upped their price objective on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, CME Group has an average rating of “Hold” and an average price target of $209.73.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.